SCHEMBL4193471

SCHEMBL4193471

C[C@@H](CC1CCCC1)NCc1ccccc1NS(=O)(=O)c1ccc(-c2cccnc2)s1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.43
KDM4E B2RXH2 3/20 0.37
F10 P00742 4/20 0.37
F2 P00734 3/20 0.37
PKM P14618 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
HPGD P15428 2/20 0.35
GAA P10253 1/20 0.35
TSHR P16473 1/20 0.35
BRAF P15056 1/20 0.35
CYP2C9 P11712 3/20 0.35
CYP2C19 P33261 3/20 0.35
CYP2D6 P10635 2/20 0.35
CYP2A6 P11509 2/20 0.35
ESR1 P03372 1/20 0.35
MAPT P10636 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ESR2 Q92731 1/20 0.35
ALDH1A1 P00352 2/20 0.34
CYP2E1 P05181 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14344109 0.99 GHSR (0.42) GHSRKDM4EF10F2PKM
SCHEMBL4197564 0.91 KDM4E (0.39) GHSRKDM4EPKMRXFP1MAPT
SCHEMBL4193846 0.90 PKM (0.38) GHSRKDM4EF10F2PKM
SCHEMBL4185970 0.90 KDM4E (0.40) GHSRKDM4EPKMRXFP1MAPT
SCHEMBL4197254 0.88 PIK3CG (0.36) GHSRKDM4EF2PKMRXFP1
SCHEMBL4190623 0.87 KDM4E (0.37) GHSRKDM4EF2PKMRXFP1
SCHEMBL4193027 0.86 KDM4E (0.36) GHSRKDM4EPKMRXFP1HPGD
SCHEMBL4194037 0.85 GHSR (0.44) GHSRKDM4EF2PKMRXFP1
SCHEMBL4197224 0.85 KDM4E (0.46) GHSRKDM4EPKMTSHRMAPT
SCHEMBL4197519 0.85 GHSR (0.43) GHSRKDM4EPKMRXFP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 GHSR 3645/4885KDM4E 3328/4885F10 2735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.